Tableaux de Dose Calculateur Mélanges & Stacks Apprendre Blog Peptides Approbations
Ouvrir le Calculateur
Tableaux de Dose  ›  pramlintide  ›  5mg
GLP-1 / Metabolic

pramlintide 5mg Protocole du Flacon

Reconstitution et dosage d'un flacon de 5mg de pramlintide — concentration par volume d'eau BAC, les unités à prélever sur une seringue U-100 et le tableau de dose sourcé.

Tous les protocoles de pramlintide
Autres tailles de flacon5 mg10 mg
Également appeléSymlin
Voiesubcutaneous
pramlintide — Tableau de dose
Chaque ligne citée
ObjectifDoseFréquenceDuréePreuveSource
Les données de dose sourcées de ce composé sont en cours de compilation.
À des fins de recherche et d'éducation uniquement. Pas un avis médical.
Comment Reconstituer pramlintide
U-100

Approche courante : reconstituer un flacon d'exemple de 5 mg de pramlintide avec de l'eau bactériostatique. Le tableau indique la concentration à trois volumes d'eau courants — utilisez le calculateur de cette page pour votre dose cible spécifique.

Eau BACConcentrationVolume / doseUnités (U-100)
1 mL5 mg/mL——
2 mL2.5 mg/mL——
3 mL1.67 mg/mL——

Les unités indiquées correspondent à une seringue à insuline U-100 (1 mL = 100 unités). Vérifiez toujours vos propres calculs avant de prélever.

What is Pramlintide?

Pramlintide — sold under the brand name Symlin — is a synthetic version of a hormone your body makes naturally called amylin. Amylin is a 37-amino-acid peptide released by the pancreas alongside insulin every time you eat.[1] In people with diabetes, amylin production is reduced or absent, which leaves an important piece of the blood-sugar puzzle missing.[6] Pramlintide is produced using recombinant DNA technology — essentially, lab-engineered bacteria build the peptide to exact specifications.[4] It is classed as an amylin analog and sits within the broader GLP-1 / metabolic peptide research category. On this page we treat it strictly as a research compound for educational purposes.

How Pramlintide Works

Think of amylin as insulin's quieter partner. Insulin is the main signal that tells cells to absorb sugar from the blood. Amylin handles three supporting jobs that insulin alone can't do:

  • Slows gastric emptying. Food moves from the stomach into the intestine more slowly, so sugar enters the bloodstream in a gentler wave instead of a flood.[1]
  • Suppresses glucagon. Glucagon is a hormone that tells the liver to release stored sugar. Amylin keeps glucagon in check after meals, preventing unnecessary sugar spikes.[1]
  • Signals the brain to stop eating. Amylin acts on areas of the brain called circumventricular organs — regions that sit outside the blood-brain barrier — to promote satiety, meaning the feeling of fullness.[1]

Pramlintide mimics all three of these actions. Because it is a peptide (a short protein chain), it must be injected rather than swallowed — stomach acid would break it down before it could do anything useful.[4]

What the Research Shows

Decades of research have built a solid picture of how amylin and pramlintide behave in the body.

A landmark 2015 review in Pharmacological Reviews laid out amylin's broad role as a glucoregulatory hormone — meaning it helps keep blood sugar balanced. The review found that amylin interacts with other metabolic hormones including leptin, cholecystokinin, and estradiol, hinting at complex, system-wide effects beyond simple glucose control.[1] The same review noted that amylin agonists (compounds that activate amylin receptors) showed promise for weight loss, particularly when combined with other agents.[1]

A 2024 review in the International Journal of Molecular Sciences described amylin as an anorexigenic hormone — a term meaning it suppresses appetite. The authors highlighted pramlintide's dual role: it addresses both glucose homeostasis and the hedonic (pleasure-driven) aspects of eating, making it relevant to research on obesity as well as diabetes.[6]

A 2025 review in Endocrine Reviews noted that pramlintide is among several agents being studied to address insulin resistance in type 1 diabetes — a condition more common in that population than previously appreciated.[2] The authors acknowledged that while promising, pramlintide's off-label use and short duration of action currently limit its wider adoption.[2]

Pramlintide's short half-life has driven researchers to look for improved versions. Scientists at Novo Nordisk developed cagrilintide, a long-acting amylin analog, partly because pramlintide requires up to three daily injections due to how quickly it clears the body.[3] This next-generation compound is now in clinical trials, including in combination with the GLP-1 analog semaglutide.[3]

What Pramlintide Is Being Studied For

  • Post-meal glucose control — reducing blood sugar spikes after eating in both type 1 and type 2 diabetes models.[1]
  • Appetite and weight regulation — amylin receptor activation promotes satiety and has shown body-weight-reducing effects in research settings.[6]
  • Insulin resistance — early-stage research suggests pramlintide may help address insulin resistance as part of a broader metabolic strategy.[2]
  • Combination metabolic therapies — researchers are exploring amylin analogs alongside GLP-1 receptor agonists and other hormones to amplify metabolic benefits.[1][3]

How Pramlintide Is Dosed in Research

Dosing protocols for pramlintide vary depending on the research context and the model being studied. Because no dosing rows have been added yet, please refer to the dosage chart on this page for specific reference ranges as they become available, and use the on-page calculator to work through weight-based dosing calculations. What is consistent across published literature is that pramlintide is administered by subcutaneous injection (under the skin) and has a notably short half-life, which in human clinical use has historically required multiple daily injections.[3] Research protocols should account for this rapid clearance when designing timing and frequency of administration.

Mixing and Storing Pramlintide

Pramlintide is a peptide, so proper handling matters. In research settings it is typically supplied as a lyophilized (freeze-dried) powder or as a pre-made solution. If working with a lyophilized form, reconstitute with the solvent specified by your supplier — commonly bacteriostatic water or sterile saline — using slow, gentle swirling rather than vigorous shaking to avoid denaturing (breaking down) the peptide. Avoid mixing pramlintide with insulin in the same syringe, as the two compounds are physically incompatible when combined.[4] Store unmixed vials in a refrigerator (around 2–8 °C / 36–46 °F) and protect them from light. Once reconstituted, follow your supplier's guidance on shelf life — peptide solutions degrade over time even when refrigerated. Always label vials with the date of reconstitution. This compound is for research use only; these mixing notes are not medical instructions.

Sources

  1. Amylin: Pharmacology, Physiology, and Clinical Potential. — Pharmacological reviews, 2015. PMID 26071095.
  2. Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance. — Endocrine reviews, 2025. PMID 39998445.
  3. Development of Cagrilintide, a Long-Acting Amylin Analogue. — Journal of medicinal chemistry, 2021. PMID 34288673.
  4. Pramlintide. — , 2012. PMID 31644254.
  5. Pramlintide. — , 2006. PMID 30000033.
  6. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. — International journal of molecular sciences, 2024. PMID 38338796.
Matériel Nécessaire

Un kit type de reconstitution et d'injection comprend :

  • Flacon(s) de peptide lyophilisé — assez pour tout le protocole
  • Eau bactériostatique pour la reconstitution
  • Seringues à insuline U-100 (une par injection)
  • Tampons d'alcool
  • Un conteneur pour objets tranchants pour une élimination sûre
Conservation, Manipulation et Injection

Conservation et manipulation

Le peptide lyophilisé est généralement conservé au réfrigérateur et à l'abri de la lumière ; une fois reconstitué avec de l'eau bactériostatique, il est habituellement réfrigéré à 2–8 °C et utilisé en quelques semaines. Suivez une technique aseptique pour éviter toute contamination, conformément aux recommandations de sécurité des injections du CDC.

Technique d'injection

Les injections sous-cutanées se font généralement dans la graisse de l'abdomen ou de la cuisse : nettoyez le site avec un tampon d'alcool, pincez la peau, insérez à l'angle recommandé et alternez les sites pour protéger les tissus. Consultez MedlinePlus pour un guide pas à pas de l'injection sous-cutanée.

Références générales de technique aseptique et d'injection à usage éducatif — elles ne sont spécifiques à aucun composé de recherche.

pramlintide FAQ

What is Pramlintide?
Pramlintide (brand name Symlin) is a lab-made analog of amylin, a natural pancreatic hormone co-released with insulin at mealtimes. It is produced using recombinant DNA technology and mimics amylin's effects on blood sugar, gastric emptying, and appetite.[1][4] In research contexts it is studied as a metabolic peptide. It is a research compound, not a general-use supplement.
How does Pramlintide work?
Pramlintide activates amylin receptors — specialized G protein-coupled receptors found mainly in circumventricular regions of the brain.[1] This triggers three key effects: it slows how quickly food leaves the stomach, suppresses post-meal glucagon release (which would otherwise raise blood sugar), and signals the brain to promote fullness, reducing appetite.[1][6]
What is Pramlintide used for in research?
Research on pramlintide covers post-meal glucose regulation, appetite suppression, and body weight reduction.[6] It is also being studied as a tool to address insulin resistance in type 1 diabetes[2] and as part of combination metabolic therapies alongside GLP-1 receptor agonists.[1][3] All applications described here are research contexts — not medical treatments.
How is Pramlintide dosed?
Pramlintide is administered by subcutaneous injection in research protocols. Its short half-life means it clears the body quickly, which has historically required multiple daily administrations in clinical studies.[3] Specific reference ranges are listed in the dosage chart on this page. Use the on-page calculator for weight-based estimates. This is research information only — not medical dosing advice.
How do you reconstitute Pramlintide?
If your research-grade pramlintide is lyophilized (freeze-dried powder), reconstitute it with the solvent your supplier specifies — typically bacteriostatic water or sterile saline. Swirl gently; do not shake. Do not mix pramlintide with insulin in the same syringe as they are physically incompatible.[4] Store vials refrigerated at 2–8 °C, away from light, and label with the reconstitution date.
Is Pramlintide safe?
Published data indicate pramlintide has not been linked to liver enzyme elevations or clinically apparent liver injury.[4] Because of its large molecular weight and short half-life, it is also considered unlikely to transfer into breast milk in significant amounts, though data remain limited.[5] All research compounds carry risks; pramlintide is not approved for self-administration, and this page does not constitute medical advice.